Analysts Have Conflicting Sentiments on These Services Companies: Republic Services (RSG) and Texas Roadhouse (TXRH)

Analysts have been eager to weigh in on the Services sector with new ratings on Republic Services (RSG – Research Report) and Texas Roadhouse (TXRH – Research Report). Republic Services (RSG) Morgan Stanley analyst Jeffrey Goldstein maintained a Buy rating on Republic Services today and set a price target of $134.00. The company's shares closed last Friday at $118.36. According to TipRanks.com, Goldstein is a 2-star analyst with an average return of 9.9% and a 100.0% success rate. Goldstein covers the Services sector, focusing on stocks such as Waste Connections, Waste Management, and H&R Block. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Republic Services with a $122.11 average price target, implying a 5.9% upside from current levels. In a report issued on July 16, Oppenheimer also maintained a Buy rating on the stock with a $121.00 price target. See today’s analyst top recommended stocks >> Texas Roadhouse (TXRH) Morgan Stanley analyst John Glass maintained a Hold rating on Texas Roadhouse today and set a price target of $106.00. The company's shares closed last Friday at $92.17. According to TipRanks.com, Glass is a 4-star analyst with an average return of 7.9% and a 66.0% success rate. Glass covers the Services sector, focusing on stocks such as Restaurant Brands International, Red Robin Gourmet, and Jack In The Box. Currently, the analyst consensus on Texas Roadhouse is a Moderate Buy with an average price target of $111.00, implying a 18.5% upside from current levels. In a report issued on July 20, Wells Fargo also maintained a Hold rating on the stock with a $99.00 price target. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Read More on RSG: Analysts’ Top Technology Picks: Plantronics (POLY), WEX (WEX) Analysts Offer Insights on Financial Companies: S&P Global (SPGI) and United Rentals (URI) Needham Sticks to Their Buy Rating for Bel Fuse (BELFA) Barrington Keeps Their Buy Rating on Superior Uniform Group (SGC) Barrington Remains a Buy on JMP Group (JMP) The post Analysts Have Conflicting Sentiments on These Services Companies: Republic Services (RSG) and Texas Roadhouse (TXRH) appeared first on TipRanks Financial Blog.

Analysts have been eager to weigh in on the Services sector with new ratings on Republic Services (RSG – Research Report) and Texas Roadhouse (TXRH – Research Report).

Republic Services (RSG)

Morgan Stanley analyst Jeffrey Goldstein maintained a Buy rating on Republic Services today and set a price target of $134.00. The company's shares closed last Friday at $118.36.

According to TipRanks.com, Goldstein is a 2-star analyst with an average return of 9.9% and a 100.0% success rate. Goldstein covers the Services sector, focusing on stocks such as Waste Connections, Waste Management, and H&R Block.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Republic Services with a $122.11 average price target, implying a 5.9% upside from current levels. In a report issued on July 16, Oppenheimer also maintained a Buy rating on the stock with a $121.00 price target.

Texas Roadhouse (TXRH)

Morgan Stanley analyst John Glass maintained a Hold rating on Texas Roadhouse today and set a price target of $106.00. The company's shares closed last Friday at $92.17.

According to TipRanks.com, Glass is a 4-star analyst with an average return of 7.9% and a 66.0% success rate. Glass covers the Services sector, focusing on stocks such as Restaurant Brands International, Red Robin Gourmet, and Jack In The Box.

Currently, the analyst consensus on Texas Roadhouse is a Moderate Buy with an average price target of $111.00, implying a 18.5% upside from current levels. In a report issued on July 20, Wells Fargo also maintained a Hold rating on the stock with a $99.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on RSG:

  • Analysts’ Top Technology Picks: Plantronics (POLY), WEX (WEX)
  • Analysts Offer Insights on Financial Companies: S&P Global (SPGI) and United Rentals (URI)
  • Needham Sticks to Their Buy Rating for Bel Fuse (BELFA)
  • Barrington Keeps Their Buy Rating on Superior Uniform Group (SGC)
  • Barrington Remains a Buy on JMP Group (JMP)

The post Analysts Have Conflicting Sentiments on These Services Companies: Republic Services (RSG) and Texas Roadhouse (TXRH) appeared first on TipRanks Financial Blog.

Source : Tip Ranks More   

What's Your Reaction?

like
0
dislike
0
love
0
funny
0
angry
0
sad
0
wow
0

Next Article

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Veracyte (VCYT)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Veracyte (VCYT – Research Report). Vertex Pharmaceuticals (VRTX) Morgan Stanley analyst Matthew Harrison maintained a Hold rating on Vertex Pharmaceuticals today and set a price target of $202.00. The company's shares closed last Friday at $201.58, close to its 52-week low of $185.33. According to TipRanks.com, Harrison is a 5-star analyst with an average return of 15.1% and a 58.7% success rate. Harrison covers the Healthcare sector, focusing on stocks such as Biohaven Pharmaceutical Holding Co, Cerevel Therapeutics Holdings, and Centessa Pharmaceuticals. Vertex Pharmaceuticals has an analyst consensus of Moderate Buy, with a price target consensus of $262.36, implying a 30.2% upside from current levels. In a report released today, Needham also assigned a Hold rating to the stock. See today’s analyst top recommended stocks >> Veracyte (VCYT) In a report released today, Tejas Savant from Morgan Stanley maintained a Sell rating on Veracyte, with a price target of $42.00. The company's shares closed last Friday at $44.56. According to TipRanks.com, Savant is a 3-star analyst with an average return of 9.5% and a 55.9% success rate. Savant covers the Healthcare sector, focusing on stocks such as Ortho Clinical Diagnostics Holdings, Akoya Biosciences, and Guardant Health. Currently, the analyst consensus on Veracyte is a Moderate Buy with an average price target of $59.00. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Read More on VRTX: Analysts Have Conflicting Sentiments on These Services Companies: Republic Services (RSG) and Texas Roadhouse (TXRH) Analysts’ Top Technology Picks: Plantronics (POLY), WEX (WEX) Analysts Offer Insights on Financial Companies: S&P Global (SPGI) and United Rentals (URI) Needham Sticks to Their Buy Rating for Bel Fuse (BELFA) Barrington Keeps Their Buy Rating on Superior Uniform Group (SGC) The post Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Veracyte (VCYT) appeared first on TipRanks Financial Blog.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Veracyte (VCYT – Research Report).

Vertex Pharmaceuticals (VRTX)

Morgan Stanley analyst Matthew Harrison maintained a Hold rating on Vertex Pharmaceuticals today and set a price target of $202.00. The company's shares closed last Friday at $201.58, close to its 52-week low of $185.33.

According to TipRanks.com, Harrison is a 5-star analyst with an average return of 15.1% and a 58.7% success rate. Harrison covers the Healthcare sector, focusing on stocks such as Biohaven Pharmaceutical Holding Co, Cerevel Therapeutics Holdings, and Centessa Pharmaceuticals.

Vertex Pharmaceuticals has an analyst consensus of Moderate Buy, with a price target consensus of $262.36, implying a 30.2% upside from current levels. In a report released today, Needham also assigned a Hold rating to the stock.

Veracyte (VCYT)

In a report released today, Tejas Savant from Morgan Stanley maintained a Sell rating on Veracyte, with a price target of $42.00. The company's shares closed last Friday at $44.56.

According to TipRanks.com, Savant is a 3-star analyst with an average return of 9.5% and a 55.9% success rate. Savant covers the Healthcare sector, focusing on stocks such as Ortho Clinical Diagnostics Holdings, Akoya Biosciences, and Guardant Health.

Currently, the analyst consensus on Veracyte is a Moderate Buy with an average price target of $59.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on VRTX:

  • Analysts Have Conflicting Sentiments on These Services Companies: Republic Services (RSG) and Texas Roadhouse (TXRH)
  • Analysts’ Top Technology Picks: Plantronics (POLY), WEX (WEX)
  • Analysts Offer Insights on Financial Companies: S&P Global (SPGI) and United Rentals (URI)
  • Needham Sticks to Their Buy Rating for Bel Fuse (BELFA)
  • Barrington Keeps Their Buy Rating on Superior Uniform Group (SGC)

The post Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Veracyte (VCYT) appeared first on TipRanks Financial Blog.

Source : Tip Ranks More   

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.